Search results
Results from the WOW.Com Content Network
Pharmally Pharmaceutical Corporation, simply known as Pharmally, is a supplier of medical equipment including face masks and face shields. According to the Securities Exchange Commission (SEC), the company was established on September 4, 2019. [ 3 ]
Yang Hongming (Chinese: 杨鸿明), [1] more commonly known as Michael Yang in the Philippines, is a Chinese businessman and is an associate of 16th Philippine President Rodrigo Duterte. Yang was linked in the Pharmally scandal which allegedly overpriced procurement contracts for medical supplies to be used by the Philippine government during ...
Unilab, Inc., commonly known as Unilab (stylized in all caps), is a Philippine pharmaceutical company headquartered in Mandaluyong, Metro Manila. [1] It specializes in a wide range of consumer healthcare products such as prescription and over-the counter medications, vitamins and food supplements, and biotechnology.
In phase 3 clinical trial results published on April 17, patients with obesity and obstructive sleep apnea who were administered tirzepatide (the active pharmaceutical ingredient shared by ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for president-elect Donald Trump and Congress on "fixing" a Biden-era law allowing the ...
Eli Lilly (NYSE: LLY) soared more than 60% from the start of the year through its peak this summer, thanks to the company's dominance in one of today's most in-demand areas: the obesity drug market.
Cathay Drug is recognized as one of the fastest-growing pharmaceutical companies in the Philippines. In 2012, it was included in the Top 20 Leading Philippine Pharmaceutical Companies based on Value in the Philippine Pharmaceutical Industry Audit [2] for ethical segment by IMS. It was also ranked second among national pharmaceutical companies ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.